Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin-3, and Catechol-O-Methyltransferase.
Saved in:
| Title: | Pharmacogenetic Testing for Predicting Methylphenidate Treatment Outcomes in Childhood Attention Deficit Hyperactivity Disorder in Turkey: Focus on Carboxylesterase 1, Latrophilin-3, and Catechol-O-Methyltransferase. |
|---|---|
| Authors: | Suzer Gamli I; Child and Adolescent Psychiatry Specialist, Istanbul Erenkoy Mental and Neurological Diseases Training and Research Hospital, Child and Adolescent Psychiatry Unit, Istanbul, Turkey., Van Veggel A; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Karaaslan RS; Child and Adolescent Psychiatry Specialist, Istanbul Erenkoy Mental and Neurological Diseases Training and Research Hospital, Child and Adolescent Psychiatry Unit, Istanbul, Turkey., Kuerec AH; Healthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Queenstown, Singapore., Marzoukah Z; Bahcesehir Unıversity, Graduate School of Health Science, Istanbul, Turkey., Adak I; Child and Adolescent Psychiatry Specialist, Istanbul Erenkoy Mental and Neurological Diseases Training and Research Hospital, Child and Adolescent Psychiatry Unit, Istanbul, Turkey., Bulut G; Department of Medical Biology, Karabuk University, Faculty of Medicine, Istanbul, Turkey., Tunc H; Bahcesehir University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, Istanbul, Turkey., Hizel CP; R&D Pharmacogenetics, OPTI-THREA, Inc., Montreal, Canada., Parlayan C; Bahcesehir University, Faculty of Medicine, Department of Biostatistics and Medical Informatics, Istanbul, Turkey., Ekinci O; Child and Adolescent Psychiatry Specialist, Istanbul Erenkoy Mental and Neurological Diseases Training and Research Hospital, Child and Adolescent Psychiatry Unit, Istanbul, Turkey., Van Schaik R; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Akin D; Biruni University Research Center (B@MER), Biruni University, Istanbul, Turkey. |
| Source: | American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics [Am J Med Genet B Neuropsychiatr Genet] 2025 Jul; Vol. 198 (5), pp. e33024. Date of Electronic Publication: 2025 Jan 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235742 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-485X (Electronic) Linking ISSN: 15524841 NLM ISO Abbreviation: Am J Med Genet B Neuropsychiatr Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-485X |
|---|---|
| DOI: | 10.1002/ajmg.b.33024 |
